[{"NetIncomeLoss_2_Q2_USD":-2045000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-2310000.0,"OperatingCostsAndExpenses_1_Q2_USD":34320000.0,"OperatingCostsAndExpenses_2_Q2_USD":63693000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":336726000.0,"InterestPaidNet_2_Q2_USD":2531000.0,"RestrictedCashCurrent_0_Q2_USD":730000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":12828000.0,"WeightedAverageNumberOfSharesRestrictedStock_1_Q2_shares":40000.0,"IncomeTaxesPaid_2_Q2_USD":0.0,"WeightedAverageNumberOfSharesRestrictedStock_2_Q2_shares":0.0,"RepaymentsOfLongTermDebt_2_Q2_USD":203210000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":46037000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":16055000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":16292000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":10069000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":19333000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":1038000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":69.79,"CommitmentsAndContingencies_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_0_Q2_USD":414505000.0,"ProceedsFromSaleOfShortTermInvestments_2_Q2_USD":179431000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":-30000.0,"ConvertibleDebtNoncurrent_0_Q2_USD":449672000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":1128000.0,"GainLossOnDispositionOfIntangibleAssets_1_Q2_USD":0.0,"GainLossOnDispositionOfIntangibleAssets_2_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":7832000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":8988000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_1_Q2_USD":7359000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":281779000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_2_Q2_USD":13012000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":0.0,"AssetsCurrent_0_Q2_USD":863624000.0,"PaymentsForProceedsFromOtherInvestingActivities_2_Q2_USD":-1809000.0,"OtherLiabilitiesFairValueDisclosure_0_Q2_USD":107000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q2_USD":3875000.0,"CostOfGoodsAndServicesSoldAmortization_2_Q2_USD":7410000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":11528000.0,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0_Q2_USD":253500000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":599000.0,"GainLossOnInvestments_1_Q2_USD":23460000.0,"GainLossOnInvestments_2_Q2_USD":-7281000.0,"Liabilities_0_Q2_USD":547933000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":6033000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-251000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.69,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.55,"AccountsReceivableNetCurrent_0_Q2_USD":41874000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":1803000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":2159000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":659000.0,"CommonStockValue_0_Q2_USD":16000.0,"AssetsFairValueDisclosure_0_Q2_USD":694724000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":16292000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-160000.0,"EarningsPerShareBasic_1_Q2_USD":1.38,"EarningsPerShareBasic_2_Q2_USD":-0.13,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":150000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":12732000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":24623000.0,"ShortTermInvestments_0_Q2_USD":694724000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":16694000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q2_position":7.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":2909000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":9181000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":115156000.0,"OtherAssetsNoncurrent_0_Q2_USD":6059000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.004,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.011,"ComprehensiveIncomeNetOfTax_1_Q2_USD":24643000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-4139000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-6977000.0,"OtherAssetsCurrent_0_Q2_USD":5489000.0,"NumberOfBusinessesAcquired_6_Q2_acquisition":2.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":150000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0_Q2_USD":414905000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-279310000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.215,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.109,"AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0_Q2_USD":488414000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":7869000.0,"AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_0_Q2_USD":73579000.0,"InterestPayableCurrent_0_Q2_USD":471000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":2742000.0,"BusinessCombinationAcquisitionRelatedCosts_6_Q2_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_1_Q2_USD":-23000.0,"NotesReceivableFairValueDisclosure_0_Q2_USD":43535000.0,"GainLossOnDispositionOfAssets1_2_Q2_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":41304000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-185000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-2064000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":7359000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":1429000.0,"Goodwill_0_Q2_USD":103369000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":-1499000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":16292000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":2000000.0,"EarningsPerShareDiluted_1_Q2_USD":1.32,"EarningsPerShareDiluted_2_Q2_USD":-0.13,"CommonStockSharesOutstanding_0_Q2_shares":16071000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":11466000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":43613000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":392893000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":1500000.0,"HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_0_Q2_USD":488084000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":2400000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":12442000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":16055000.0,"AccountsPayableCurrent_0_Q2_USD":6103000.0,"NetIncomeLoss_1_Q2_USD":22086000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":7883000.0,"AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_0_Q2_USD":73509000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-1134000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":292000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":23340000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":46037000.0,"LiabilitiesCurrent_0_Q2_USD":29264000.0,"AdditionalPaidInCapital_0_Q2_USD":304404000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":215295000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1858000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1550000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":115886000.0,"InterestExpense_1_Q2_USD":6213000.0,"InterestExpense_2_Q2_USD":14761000.0,"NonoperatingIncomeExpense_1_Q2_USD":21019000.0,"NonoperatingIncomeExpense_2_Q2_USD":-13184000.0,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":8890000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":74581000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":41420000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2_Q2_USD":452405000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":73287000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":28119000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-2296000.0,"OperatingIncomeLoss_1_Q2_USD":7100000.0,"OperatingIncomeLoss_2_Q2_USD":10888000.0,"CommonStockSharesAuthorized_0_Q2_shares":60000000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1_Q2_USD":2742000.0,"PaymentsToAcquireBusinessesGross_2_Q2_USD":15140000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":8673000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"IncreaseDecreaseInOtherCurrentLiabilities_2_Q2_USD":3140000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OperatingLeaseRightOfUseAsset_0_Q2_USD":9689000.0,"ShareBasedCompensation_2_Q2_USD":13012000.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":3553000.0,"Assets_0_Q2_USD":1242936000.0,"ProceedsFromSaleOfIntangibleAssets_2_Q2_USD":0.0,"CommonStockSharesIssued_0_Q2_shares":16071000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":26411000.0,"InventoryNet_0_Q2_USD":3702000.0,"IncomeTaxesReceivable_0_Q2_USD":2679000.0,"StockRepurchasedDuringPeriodValue_1_Q2_USD":0.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-1198000.0,"CostDirectMaterial_1_Q2_USD":7644000.0,"CostDirectMaterial_2_Q2_USD":12327000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":318664000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":695003000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":26471000.0,"ProfitLoss_2_Q2_USD":-2045000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1728000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q2_USD":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":3457000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1242936000.0,"PreferredStockValue_0_Q2_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":8917000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"InvestmentIncomeInterest_1_Q2_USD":1969000.0,"InvestmentIncomeInterest_2_Q2_USD":6699000.0,"EquitySecuritiesFvNi_0_Q2_USD":8816000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":964000.0,"Ticker":"LGND","CIK":"886163","name":"LIGAND PHARMACEUTICALS INC","OfficialName":"Ligand Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"1738856427.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200807"}]